CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-27 | Chen Hongming CHIEF SCIENTIFIC OFFICER | Sale | −21,051 | $1.82 | $38K | 204,515 |
| 2021-10-26 | Chen Hongming CHIEF SCIENTIFIC OFFICER | Sale | −9,449 | $1.80 | $17K | 225,566 |
| 2021-06-29 | Chen Hongming CHIEF SCIENTIFIC OFFICER | Sale | −5,548 | $5.56 | $31K | 235,015 |
| 2021-06-28 | Chen Hongming CHIEF SCIENTIFIC OFFICER | Sale | −2,452 | $5.77 | $14K | 240,563 |
| 2021-03-01 | Chen Hongming Chief Scientific Officer | Exercise or conversion | +9,500 | $2.30 | $22K | 243,015 |
| 2021-03-01 | Chen Hongming Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy | −9,500 | 53,736 | ||
| 2021-02-25 | Chen Hongming Chief Scientific Officer | Exercise or conversion | +47,000 | $2.30 | $108K | 233,515 |
| 2021-02-25 | Chen Hongming Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −47,000 | 63,236 | ||
| 2021-01-04 | Chen Hongming Chief Scientific Officer | Grant or award | +22,666 | 186,515 | ||
| 2021-01-04 | Chen Hongming Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +90,667 | 90,667 | ||
| 2020-10-26 | Chen Hongming Chief Scientific Officer | Grant or award | +61,000 | 163,849 | ||
| 2020-06-25 | Chen Hongming Chief Scientific Officer | Grant or award | +16,000 | 102,849 | ||
| 2020-03-30 | Chen Hongming Chief Scientific Officer | Exercise or conversion | +31,000 | $2.30 | $71K | 86,849 |
| 2020-03-30 | Chen Hongming Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −31,000 | 75,236 | ||
| 2020-01-02 | Chen Hongming Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2019-01-02 | Chen Hongming Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-02-28 | Chen Hongming Chief Scientific Officer | Exercise or conversion | +4,000 | $2.30 | $9K | 50,080 |
| 2018-02-28 | Chen Hongming Chief Scientific Officer | Exercise or conversion | +5,769 | $2.24 | $13K | 55,849 |
| 2018-02-28 | Chen Hongming Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −4,000 | 106,236 | ||
| 2018-02-28 | Chen Hongming Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −5,769 | 0 |
Page 1 of 2 · 22 trades